Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07097792 · ClinicalTrials.gov registry record · NA
Concussion Recovery and Support Program
A NA study of Mild Traumatic Brain Injury and Headache, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT07097792: Recruiting NA study of Mild Traumatic Brain Injury and Headache, sponsored by Seattle Children's Hospital.
NCT07097792 is a NA study of Mild Traumatic Brain Injury and Headache that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 40 participants, below the 220-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07097792, a NA study of Mild Traumatic Brain Injury and Headache, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
Pilot randomized controlled trial (RCT) comparing a novel intervention Concussion Recovery and Support Program (CRISP) for adolescents and young adults (AYA) 18-29 yo with concussion/ mild TBI.
Primary Outcome
Self-report form regarding acceptability of treatment approach. Minimum 0, maximum 24 (6 items x 4 likert), higher scores indicate higher rating of treatment acceptability.
Conditions Studied
Interventions
- BEHAVIORAL CRISP (Concussion Recovery and Support Program)
Study Locations (2)
Washington
- Seattle Children's Research Institute - Seattle
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-10-13 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT07097792 shows while recruiting
NCT07097792 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 220-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which CRISP (Concussion Recovery and Support Program) is the first listed.
NCT07097792 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07097792 about?
NCT07097792 is a clinical study titled "Concussion Recovery and Support Program". Pilot randomized controlled trial (RCT) comparing a novel intervention Concussion Recovery and Support Program (CRISP) for adolescents and young adults (AYA) 18-29 yo with concussion/ mild TBI.
What is the current status of trial NCT07097792?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-10-13. Estimated completion is 2026-07-31.
What conditions does trial NCT07097792 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Headache, Brain Concussion.
What interventions are being tested in trial NCT07097792?
The interventions under investigation include: CRISP (Concussion Recovery and Support Program) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07097792?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07097792 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07097792's enrollment target sits among peer trials
40 35th of 43 higher than 9 of 43 other Mild Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
RECRUITING · NA
-
Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury
RECRUITING · NA
-
Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms
RECRUITING · NA
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
rTMS for Military TBI-related Depression
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI